Cargando…

Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors

Extensive desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), which frequently associates with treatment resistance. Recent findings indicate that a combination of photodynamic therapy and the multi-kinase inhibitor cabozantinib achieved local tumor control and a significant decrea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broekgaarden, Mans, Alkhateeb, Ahmed, Bano, Shazia, Bulin, Anne-Laure, Obaid, Girgis, Rizvi, Imran, Hasan, Tayyaba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352584/ https://www.ncbi.nlm.nih.gov/pubmed/32485915 http://dx.doi.org/10.3390/cancers12061401

Ejemplares similares

Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids
por: Bulin, Anne-Laure, et al.
Publicado: (2017)

Low dose photodynamic therapy harmonizes with radiation therapy to induce beneficial effects on pancreatic heterocellular spheroids
por: Bulin, Anne-Laure, et al.
Publicado: (2019)

Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids
por: Broekgaarden, Mans, et al.
Publicado: (2018)

Tracking Photodynamic- and Chemotherapy-Induced Redox-State Perturbations in 3D Culture Models of Pancreatic Cancer: A Tool for Identifying Therapy-Induced Metabolic Changes
por: Broekgaarden, Mans, et al.
Publicado: (2019)

Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy
por: Mallidi, Srivalleesha, et al.
Publicado: (2016)

Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis: Emerging Perspectives
por: Xu, Si, et al.
Publicado: (2020)

NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer
por: Bano, Shazia, et al.
Publicado: (2020)

Photoimmunotherapy retains its anti-tumor efficacy with increasing stromal content in heterotypic pancreatic cancer spheroids
por: Saad, Mohammad A., et al.
Publicado: (2022)

Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung
por: Lugo, Roberto, et al.
Publicado: (2016)

Liposomal Lapatinib in Combination with Low-Dose Photodynamic Therapy for the Treatment of Glioma
por: Fisher, Carl, et al.
Publicado: (2019)

3D microtumors in vitro supported by perfused vascular networks
por: Sobrino, Agua, et al.
Publicado: (2016)

Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors
por: Sagami, Ryota, et al.
Publicado: (2017)

Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW
por: Bhandari, Chanda, et al.
Publicado: (2022)

Study on the Effect of Different Endoscopic Auxiliary Treatment of Gastric Mucosal Microtumor
por: Zhong, Xiongping, et al.
Publicado: (2022)

Infantile fibrosarcoma–like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib
por: Gupta, Ajay, et al.
Publicado: (2020)

Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase
por: Sachkova, Anastasia A., et al.
Publicado: (2022)

Dramatic Response to Cabozantinib in a Patient with Refractory Hepatocellular Carcinoma with c-MET Amplification
por: Sang, Yun Beom, et al.
Publicado: (2023)

Functional profiling of microtumors to identify cancer associated fibroblast-derived drug targets
por: Horman, Shane R., et al.
Publicado: (2017)

Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization — a Thomas Dougherty Award for Excellence in PDT paper
por: De Silva, Pushpamali, et al.
Publicado: (2020)

Auto/paracrine nicotinergic peptides participate in cutaneous stress response to wounding
por: Chernyavsky, Alex I., et al.
Publicado: (2012)

Enrichment of c-Met(+) tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib
por: Liu, L, et al.
Publicado: (2014)

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma
por: Daud, Adil, et al.
Publicado: (2017)

In Vitro Microtumors Provide a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening
por: Benton, Gabriel, et al.
Publicado: (2015)

Microfluidic-Based 3D Engineered Microvascular Networks and Their Applications in Vascularized Microtumor Models
por: Wang, Xiaolin, et al.
Publicado: (2018)

Targeting Estrogen Receptor-Positive Breast Microtumors with Endoxifen-Conjugated, Hypoxia-Sensitive Polymersomes
por: Mamnoon, Babak, et al.
Publicado: (2021)

Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
por: Broekgaarden, Mans, et al.
Publicado: (2015)

Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D in vitro heterocellular model of pancreatic cancer
por: De Silva, Pushpamali, et al.
Publicado: (2021)

Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts
por: van Driel, Marjolein, et al.
Publicado: (2023)

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
por: Hage, C, et al.
Publicado: (2013)

Cabozantinib, a Novel c-Met Inhibitor, Inhibits Colorectal Cancer Development in a Xenograft Model
por: Sun, Yinggang, et al.
Publicado: (2015)

A human vascularized microtumor model of patient-derived colorectal cancer recapitulates clinical disease
por: Hachey, Stephanie J., et al.
Publicado: (2023)

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma
por: Hagege, Anais, et al.
Publicado: (2022)

The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations
por: Jóri, Balázs, et al.
Publicado: (2023)

Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy
por: Broekgaarden, Mans, et al.
Publicado: (2015)

Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells
por: Jang, Minjeong, et al.
Publicado: (2017)

Shift from stochastic to spatially-ordered expression of serine-glycine synthesis enzymes in 3D microtumors
por: Singh, Manjulata, et al.
Publicado: (2018)

Three-Dimensional Imaging for Multiplex Phenotypic Analysis of Pancreatic Microtumors Grown on a Minipillar Array Chip
por: Oh, Min-Suk, et al.
Publicado: (2020)

A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer
por: Anderle, Nicole, et al.
Publicado: (2022)

Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening
por: Li, Yanan, et al.
Publicado: (2022)

Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rhg1thnppnkktjg4nk26qq1i3q